Maple Capital Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $305K | Sell |
568
-5
| -0.9% | -$2.68K | 0.02% | 95 |
|
|
2025
Q1 | $241K | Buy |
573
+5
| +0.9% | +$2.1K | 0.02% | 109 |
|
|
2024
Q4 | $235K | Hold |
568
| – | – | 0.02% | 101 |
|
|
2024
Q3 | $287K | Hold |
568
| – | – | 0.02% | 98 |
|
|
2024
Q2 | $277K | Sell |
568
-37
| -6% | -$18K | 0.02% | 102 |
|
|
2024
Q1 | $327K | Hold |
605
| – | – | 0.03% | 90 |
|
|
2023
Q4 | $336K | Hold |
605
| – | – | 0.03% | 78 |
|
|
2023
Q3 | $265K | Hold |
605
| – | – | 0.03% | 85 |
|
|
2023
Q2 | $304K | Sell |
605
-20
| -3% | -$10K | 0.03% | 80 |
|
|
2023
Q1 | $313K | Sell |
625
-8
| -1% | -$4K | 0.04% | 79 |
|
|
2022
Q4 | $258K | Buy |
633
+4
| +0.6% | +$1.63K | 0.03% | 82 |
|
|
2022
Q3 | $269K | Sell |
629
-15
| -2% | -$6.42K | 0.03% | 82 |
|
|
2022
Q2 | $226K | Sell |
644
-16
| -2% | -$5.62K | 0.03% | 85 |
|
|
2022
Q1 | $361K | Sell |
660
-5
| -0.8% | -$2.74K | 0.04% | 78 |
|
|
2021
Q4 | $438K | Hold |
665
| – | – | 0.05% | 74 |
|
|
2021
Q3 | $414K | Hold |
665
| – | – | 0.05% | 74 |
|
|
2021
Q2 | $447K | Sell |
665
-20
| -3% | -$13.4K | 0.05% | 75 |
|
|
2021
Q1 | $335K | Hold |
685
| – | – | 0.05% | 76 |
|
|
2020
Q4 | $342K | Sell |
685
-6
| -0.9% | -$3K | 0.05% | 78 |
|
|
2020
Q3 | $313K | Hold |
691
| – | – | 0.05% | 81 |
|
|
2020
Q2 | $228K | Buy |
+691
| New | +$228K | 0.04% | 93 |
|
|
2019
Q3 | – | Sell |
-734
| Closed | -$202K | – | 123 |
|
|
2019
Q2 | $202K | Buy |
+734
| New | +$202K | 0.05% | 120 |
|